Stories from the dialysis comunity across the globe.
FCTA to Procure Dialysis Facilities - AllAfrica.com
The FCT Administration said Friday that it has concluded arrangements to establish a world-class dialysis unit in Abuja.
FCT Minister, Senator Bala Abdulkadir Mohammed, who said this in Abuja, also disclosed that approval has already been given to the FCT Health and Human Services Secretariat to urgently make the facilities available to combat the alarming cases of kidney diseases in the country and FCT in particular.
Senator Mohammed further disclosed that approval has been given for the procurement and installation of an Operative Laposcope for general surgery, gynecology and Urology, as well as endoscope to upper and lower gastrointestinal track.
The minister stated that his administration made provision in the 2012 statutory budget of the FCT to procure as well as install a 1.5 Tesla MRI machine in Asokoro District Hospital and a 64-Slice Computerized Tomography (CT) Scanner at Maitama District Hospital.
Senator Mohammed said that the FCT Administration has already procured, installed and commissioned some sensitive modern medical equipment under radiology, which he said included a 64-Slice Computerized Tomography (CT) Scanner as well as Digital Fluoroscope X-Ray machine at the Asokoro District Hospital.
He stated further that his administration has been able to procure and install a Mammography machine for detecting breast cancer at Maitama District Hospital.
The minister said a lot of investments was made to provide basic medical infrastructure in Abuja as the Asokoro District Hospital now has Ultra-Sound and Echo Cardiograph machine (HD 11 machine) which is believed to be the only one in the country; while four new Static X-Ray machines have been installed in Gwarinpa, Wuse, Maitama and Kubwa General Hospitals respectively.
"The FCT Administration has also procured four new Mobile X-Ray Units which has been deployed to Asokoro, Maitama, Wuse and Gwarinpa District Hospitals; apart from the four new HD3 Ultra-Sound Machines (Philips) for Maitama, Gwarinpa, Wuse District and Nyanya General Hospitals, to help check pregnant women and patients with liver or abdominal medical cases," the minister added.
New Benton Harbor dialysis treatment center will be more than 8700 square feet - south west michigan
Related Tags
Obtaining dialysis treatment will soon be easier for those needing it in Benton Harbor.
A new 8,740-square-foot outpatient dialysis treatment is going up at 338 8th St.
The new center is a partnership between Liberty Dialysis, Lakeland HealthCare, and Lake Michigan Nephrology. Officials from Liberty Dialysis, Lakeland HealthCare, and Lake Michigan Nephrology broke ground June 26 on the treatment center.
Liberty Dialysis works with local physicians and non-profit organizations to develop clinics in underserved communities. Liberty Dialysis develops, owns and operates dialysis clinics throughout the United States abd enters into partnerships with local nephrologists and hospitals in owning and operating these centers.
"Kidney dialysis is a major issue for many residents in Benton Harbor," says Dr. Katie Kwon, of Lake Michigan Nephrology. "Patients currently have to travel three times a week for treatment, and this facility will help them better manage this chronic disease."
The project is another in a growing number of businesses and service companies that are choosing to make Benton Harbor home, says Dan Hopp, vice chair of Cornerstone Alliance board and chairman of the Lakeland HealthCare board.
Construction of the new center "brings a much-needed service to the over 80 patients from the City of Benton Harbor who receive treatment at other facilities," Hopp says.
Writer: Kathy Jennings, Southwest Michigan Second Wave Source: Laura Bailey, Lakeland HealthCare
Give us your email and we will give you our weekly online magazine. Fair?
New Benton Harbor dialysis treatment center will be more than 8700 ... - south west michigan
Related Tags
Obtaining dialysis treatment will soon be easier for those needing it in Benton Harbor.
A new 8,740-square-foot outpatient dialysis treatment is going up at 338 8th St.
The new center is a partnership between Liberty Dialysis, Lakeland HealthCare, and Lake Michigan Nephrology. Officials from Liberty Dialysis, Lakeland HealthCare, and Lake Michigan Nephrology broke ground June 26 on the treatment center.
Liberty Dialysis works with local physicians and non-profit organizations to develop clinics in underserved communities. Liberty Dialysis develops, owns and operates dialysis clinics throughout the United States abd enters into partnerships with local nephrologists and hospitals in owning and operating these centers.
"Kidney dialysis is a major issue for many residents in Benton Harbor," says Dr. Katie Kwon, of Lake Michigan Nephrology. "Patients currently have to travel three times a week for treatment, and this facility will help them better manage this chronic disease."
The project is another in a growing number of businesses and service companies that are choosing to make Benton Harbor home, says Dan Hopp, vice chair of Cornerstone Alliance board and chairman of the Lakeland HealthCare board.
Construction of the new center "brings a much-needed service to the over 80 patients from the City of Benton Harbor who receive treatment at other facilities," Hopp says.
Writer: Kathy Jennings, Southwest Michigan Second Wave Source: Laura Bailey, Lakeland HealthCare
Give us your email and we will give you our weekly online magazine. Fair?
A valid email address is required.
Invalid email format, please check email format.
FDA terms relabeling of Naturalyte and Granuflo concentrates to warn of total base content and alkalosis risk as a Class I recall.
FDA: The manufacturer is cautioning clinicians to be aware of the concentration of acetate or sodium diacetate (acetic acid plus acetate) contained in Fresenius' Naturalyte Liquid and Granuflo Dry Acid Concentrate. Inappropriate prescription of these products can lead to a high serum bicarbonate level in patients undergoing hemodialysis. This may contribute to metabolic alkalosis, which is a significant risk factor associated with low blood pressure, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately treated, may culminate in cardiopulmonary arrest. This product may cause serious adverse health consequences, including death.
Fresenius changes its labeling on its Naturalyte and Granuflo dialysate concentrates to reflect total base content.
FMC: Fresenius Medical Care North America (FMCNA) announced today that the Food and Drug Administration (FDA) has classified FMCNA’s voluntary action to change the labeling on its dialysate products as a Class 1 recall. In conjunction with this classification, and to further reinforce the importance of correct dialysate dosing, FMCNA will continue its process to place updated labels on its NaturaLyte and GranuFlo Acid Concentrate products, and to update its hemodialysis machine operator’s manuals. To date, FMCNA has notified more than 90 percent of its customers of these two labeling updates, and will continue with that effort until it is complete. The FDA’s action does not involve the removal of any FMCNA products from the marketplace.
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
